Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @NatureRevCancer
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @NatureRevCancer
-
Prikvačeni tweet
Our first issue of 2020: a
#focus on#brain tumours! Read our#editorial http://bit.ly/brainfocus-ed to find out what our Jan issue is about: the challenges presented by brain#tumours, and the progress that is being made on many different fronts in this research field.@NatResCancerpic.twitter.com/Tkp5wSQXNp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NatureReviewsCancer proslijedio/la je Tweet
What is the
#Warburg effect and how does it fit with our modern understanding of#cancer biology?@RJDLab and#notwitternav clarify common misconceptions. Read it here (https://rdcu.be/b1bjD ) or below.#metabolismhttps://www.nature.com/articles/s42255-020-0172-2 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In recognition of
#WorldCancerDay
why not have a read of our article from Bin Tean Teh @dukenus who argues that genomic & epigenomic studies on#cancer in diverse populations are essential in order to reduce worldwide cancer burden & improve global health https://go.nature.com/2JWxuPq pic.twitter.com/gALjZJB6Nh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In recognition of
#WorldCancerDay
why not have a read of our article by @Chris_P_Wild Former Director@IARCWHO, discussing the increasing health & economic burden of cancer worldwide & calling for investment to ensure long-term cancer prevention strategies https://go.nature.com/2HzJaa8 pic.twitter.com/JOLotq6DtZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In
@NatureCancer, Brid Ryan@Sanjusinha7@NCIResearchCtr demonstrate higher frequency of homologous recombination deficiency in tumours from African Americans than European Americans - call for diverse pop'ns in cancer genomics studies#ResearchHighlight https://go.nature.com/31aTKuu pic.twitter.com/TXaPNP4YA8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NatureReviewsCancer proslijedio/la je Tweet
Join us at
#HCINatureTCI20 with@huntsmancancer &@NatureRevCancer! Register by Feb 29 for a discounted price: https://umarket.utah.edu/um2/hcisymposium/ …pic.twitter.com/RLtFD2DqK5
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In our FEBRUARY issue out NOW we have all of this: the PI3K–AKT signalling network in
#cancermetabolism; the ageing microenvironment in tumour progression; fluids & mechanics of metastatic dissemination; dietary patterns &#cancer risk https://go.nature.com/2GyeYJi@NatResCancerpic.twitter.com/QROqXyDchG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our
#openaccess Consensus Statement provides a framework for advancing our understanding of cancer-associated fibroblasts authored by 29 leaders in the field! Why not have a read here....https://go.nature.com/2vs60uX@NatResCancer@CSHL@cshlbanburypic.twitter.com/pe5UNwbLWz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Take a look at our NEW Review by Ali H. Zahalka & Paul S. Frenette
@EinsteinMed on the role#nerves play in the initiation & progression of cancers. Is the recruitment of nerves an emerging hallmark of#cancer? https://go.nature.com/2TSIf9t@NatResCancerpic.twitter.com/JLeNTlTAgu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
3
@Nature papers have shown that B cells & TLSs are associated with survival &#immunotherapy response in#cancer.#edpicks For#FurtherReading check out our Review on TLSs in cancer by the authors of 1 of the papers@sautesfridm,@petitprez_f,@fridmanwh https://go.nature.com/30nPTcE https://twitter.com/nature/status/1217579529138556933 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Abstract submission deadline TODAY! Submit now for a chance at travel awards and to present your work (posters & short talks) at our
@NatureConf with@huntsmancancer@UUtah on using cancer biology to improve detection & prevention.#HCINatureTCI20 Go to: http://bit.ly/TCI20 pic.twitter.com/TpFxIhyuLz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NatureReviewsCancer proslijedio/la je Tweet
Researchers speak out in the largest ever survey of
#ResearchCulture. It's time for change, and everyone can help#ReimagineResearch
See the results and help decide what happens next: https://wellc.me/2FvE7nz Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our NEW Review by Vishwakarma & Piddini
@epiddin discusses how cell competition between tumour cells & neighbouring epithelial host cells may dictate tumorigenesis & proposes manipulating cell competition as an orthogonal therapeutic strategy https://go.nature.com/30m2HAX@NatResCancerpic.twitter.com/pZLlJOfdx9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Massive congratulations to our colleagues
@NatureCancer on their first full issue! It looks great!https://twitter.com/NatureCancer/status/1216760598383472641 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NatureReviewsCancer proslijedio/la je Tweet
Too busy over the holidays? -- Abstracts now accepted until *JANUARY 20th*! Take part in a truly transdisciplinary conference that brings together top speakers in an amazing setting.
@huntsmancancer@AlanaWelm@HolmenSheri@BryanWelm@TomVargheseJr@neerajaiims@SheetalHardikarhttps://twitter.com/NatureRevCancer/status/1214939820872499200 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Abstract submission deadline extended to Jan 20! Submit now for a chance at travel awards and to give a short talk at our
@NatureConf with@huntsmancancer@UUtah on using cancer biology to improve detection & prevention.#HCINatureTCI20 Go to: http://bit.ly/TCI20 pic.twitter.com/S6nOEBK63q
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NatureReviewsCancer proslijedio/la je Tweet
Great news, due to popular demand the abstract submission deadline for
#HCINatureTCI20 has been extended until January 20! Click on the picture to submit.@Huntsmancancer@UUtah@NatureRevCancerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our NEW Review by
@VetrieLab@CoplandMhairi & G. Vignir Helgason discusses many of the similarities & differences between#leukaemia stem cells in#CML &#AML & examines the therapeutic strategies that could be used to eradicate them. https://go.nature.com/37TKw8j@NatResCancerpic.twitter.com/iLlKiheNsx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NatureReviewsCancer proslijedio/la je Tweet
Present your research at
#HCINatureTCI20! Today is the final day to submit your abstract and potentially win a travel grant. http://go.nature.com/31qyNds@Huntsmancancer,@UUtah,@NatureRevCancerpic.twitter.com/kZC13gbaCk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Don't forget! Just 2 days left to submit your abstract for a chance at travel awards and to give a short talk at our
@NatureConf with@huntsmancancer@UUtah on using cancer biology to improve detection & prevention.#HCINatureTCI20 Go to: http://bit.ly/TCI20 pic.twitter.com/SM9n75NoMB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NatureReviewsCancer proslijedio/la je Tweet
Abstract deadline Jan 6 – apply for travel awards! Top speakers for our
@huntsmancancer@uutah@naturerevcancer conference on cancer biology, interception & prevention:@evilarsan@AllisonKurian@DrSancy@SerenaNikZainal@folopade@chiragjp@Vi8tor. Go to: http://bit.ly/TCI20 pic.twitter.com/qPdib8BABq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
WE HAVE SOMETHING TO CELEBRATE: OUR FIRST FULL ISSUE
- GIVE US BIGGER CAPS TO SHOW OUR EXCITEMENT!!